235 related articles for article (PubMed ID: 25209109)
1. Nuclear factor-κB activation inhibitor attenuates ischemia reperfusion injury and inhibits Hmgb1 expression.
Shi Z; Lian A; Zhang F
Inflamm Res; 2014 Nov; 63(11):919-25. PubMed ID: 25209109
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of DHMEQ, a NF-κB inhibitor, in islet transplantation: I. HMGB1 suppression by DHMEQ prevents early islet graft damage.
Kuraya D; Watanabe M; Koshizuka Y; Ogura M; Yoshida T; Asahi Y; Kamachi H; Nakamura T; Harashima H; Ozaki M; Umezawa K; Matsushita M; Yamashita K; Todo S
Transplantation; 2013 Sep; 96(5):445-53. PubMed ID: 23900151
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of DHMEQ, a NF-κB inhibitor, in islet transplantation: II. Induction DHMEQ treatment ameliorates subsequent alloimmune responses and permits long-term islet allograft acceptance.
Watanabe M; Yamashita K; Kamachi H; Kuraya D; Koshizuka Y; Shibasaki S; Asahi Y; Ono H; Emoto S; Ogura M; Yoshida T; Ozaki M; Umezawa K; Matsushita M; Todo S
Transplantation; 2013 Sep; 96(5):454-62. PubMed ID: 23860082
[TBL] [Abstract][Full Text] [Related]
4. Hmgb1-TLR4-IL-23-IL-17A axis promote ischemia-reperfusion injury in a cardiac transplantation model.
Zhu H; Li J; Wang S; Liu K; Wang L; Huang L
Transplantation; 2013 Jun; 95(12):1448-54. PubMed ID: 23677049
[TBL] [Abstract][Full Text] [Related]
5. Control of allograft rejection by applying a novel nuclear factor-kappaB inhibitor, dehydroxymethylepoxyquinomicin.
Ueki S; Yamashita K; Aoyagi T; Haga S; Suzuki T; Itoh T; Taniguchi M; Shimamura T; Furukawa H; Ozaki M; Umezawa K; Todo S
Transplantation; 2006 Dec; 82(12):1720-7. PubMed ID: 17198266
[TBL] [Abstract][Full Text] [Related]
6. Netrin-1 attenuates cardiac ischemia reperfusion injury and generates alternatively activated macrophages.
Mao X; Xing H; Mao A; Jiang H; Cheng L; Liu Y; Quan X; Li L
Inflammation; 2014 Apr; 37(2):573-80. PubMed ID: 24234226
[TBL] [Abstract][Full Text] [Related]
7. A novel NF-κB inhibitor, dehydroxymethylepoxyquinomicin, ameliorates inflammatory colonic injury in mice.
Funakoshi T; Yamashita K; Ichikawa N; Fukai M; Suzuki T; Goto R; Oura T; Kobayashi N; Katsurada T; Ichihara S; Ozaki M; Umezawa K; Todo S
J Crohns Colitis; 2012 Mar; 6(2):215-25. PubMed ID: 22325176
[TBL] [Abstract][Full Text] [Related]
8. Necrostatin-1 inhibits Hmgb1-IL-23/IL-17 pathway and attenuates cardiac ischemia reperfusion injury.
Zhang A; Mao X; Li L; Tong Y; Huang Y; Lan Y; Jiang H
Transpl Int; 2014 Oct; 27(10):1077-85. PubMed ID: 24810904
[TBL] [Abstract][Full Text] [Related]
9. The novel NF-kappaB inhibitor, dehydroxymethylepoxyquinomicin, prevents local and remote organ injury following intestinal ischemia/reperfusion in rats.
Suzuki T; Yamashita K; Jomen W; Ueki S; Aoyagi T; Fukai M; Furukawa H; Umezawa K; Ozaki M; Todo S
J Surg Res; 2008 Sep; 149(1):69-75. PubMed ID: 18599083
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA 26a inhibits HMGB1 expression and attenuates cardiac ischemia-reperfusion injury.
Yao L; Lv X; Wang X
J Pharmacol Sci; 2016 May; 131(1):6-12. PubMed ID: 26320674
[TBL] [Abstract][Full Text] [Related]
11. Donor pretreatment with DHMEQ improves islet transplantation.
Takahashi T; Matsumoto S; Matsushita M; Kamachi H; Tsuruga Y; Kasai H; Watanabe M; Ozaki M; Furukawa H; Umezawa K; Todo S
J Surg Res; 2010 Sep; 163(1):e23-34. PubMed ID: 20638688
[TBL] [Abstract][Full Text] [Related]
12. Targeting of nuclear factor kappaB Pathways by dehydroxymethylepoxyquinomicin, a novel inhibitor of breast carcinomas: antitumor and antiangiogenic potential in vivo.
Matsumoto G; Namekawa J; Muta M; Nakamura T; Bando H; Tohyama K; Toi M; Umezawa K
Clin Cancer Res; 2005 Feb; 11(3):1287-93. PubMed ID: 15709200
[TBL] [Abstract][Full Text] [Related]
13. Long pentraxin PTX3 attenuates ischemia reperfusion injury in a cardiac transplantation model.
Zhu H; Cui D; Liu K; Wang L; Huang L; Li J
Transpl Int; 2014 Jan; 27(1):87-95. PubMed ID: 24112130
[TBL] [Abstract][Full Text] [Related]
14. Dehydroxymethylepoxyquinomicin, a novel nuclear factor-κB inhibitor, prevents the development of cyclosporine A nephrotoxicity in a rat model.
Morita S; Shinoda K; Yoshida T; Shimoda M; Kanno Y; Mizuno R; Kono H; Asanuma H; Nakagawa K; Umezawa K; Oya M
BMC Pharmacol Toxicol; 2020 Aug; 21(1):60. PubMed ID: 32787951
[TBL] [Abstract][Full Text] [Related]
15. Immunomodulatory effect of nuclear factor-κB inhibition by dehydroxymethylepoxyquinomicin in combination with donor-specific blood transfusion.
Goto R; Yamashita K; Aoyagi T; Ueki S; Uno M; Oura T; Kobayashi N; Igarashi R; Shibasaki S; Wakayama K; Hirokata G; Shibata T; Zaitsu M; Umezawa K; Ozaki M; Todo S
Transplantation; 2012 Apr; 93(8):777-86. PubMed ID: 22357176
[TBL] [Abstract][Full Text] [Related]
16. Protective effect of glycyrrhizin on coronary microembolization-induced myocardial dysfunction in rats.
Yuan Y; Li B; Peng W; Xu Z
Pharmacol Res Perspect; 2021 Feb; 9(1):e00714. PubMed ID: 33507583
[TBL] [Abstract][Full Text] [Related]
17. Induction of thyroid cancer cell apoptosis by a novel nuclear factor kappaB inhibitor, dehydroxymethylepoxyquinomicin.
Starenki DV; Namba H; Saenko VA; Ohtsuru A; Maeda S; Umezawa K; Yamashita S
Clin Cancer Res; 2004 Oct; 10(20):6821-9. PubMed ID: 15501958
[TBL] [Abstract][Full Text] [Related]
18. Dehydroxymethylepoxyquinomicin, a novel nuclear factor-kappaB inhibitor, induces apoptosis in multiple myeloma cells in an IkappaBalpha-independent manner.
Tatetsu H; Okuno Y; Nakamura M; Matsuno F; Sonoki T; Taniguchi I; Uneda S; Umezawa K; Mitsuya H; Hata H
Mol Cancer Ther; 2005 Jul; 4(7):1114-20. PubMed ID: 16020669
[TBL] [Abstract][Full Text] [Related]
19. DHMEQ, a novel NF-kappaB inhibitor, induces apoptosis and cell-cycle arrest in human hepatoma cells.
Nishimura D; Ishikawa H; Matsumoto K; Shibata H; Motoyoshi Y; Fukuta M; Kawashimo H; Goto T; Taura N; Ichikawa T; Hamasaki K; Nakao K; Umezawa K; Eguchi K
Int J Oncol; 2006 Sep; 29(3):713-9. PubMed ID: 16865289
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of IkappaB phosphorylation in cardiomyocytes attenuates myocardial ischemia/reperfusion injury.
Onai Y; Suzuki J; Kakuta T; Maejima Y; Haraguchi G; Fukasawa H; Muto S; Itai A; Isobe M
Cardiovasc Res; 2004 Jul; 63(1):51-9. PubMed ID: 15194461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
